Who Paid My Doc
Long-Term Evaluation of BIIB067
Research payments
$7,486,228
Through program year 2021, $7,486,228 in research payments was reported against Long-Term Evaluation of BIIB067, across 69 payments, paid by Biogen, Inc..
- Paid by
- Biogen, Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
3 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2021 | Research | $2,808,895 | 24 |
| 2020 | Research | $3,580,582 | 27 |
| 2019 | Research | $1,096,751 | 18 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
9 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- John Glass Atlanta, GA Named on 6 payments
- John Ravits La Jolla, CA Named on 5 payments
- Robert Bucelli Saint Louis, MO Named on 3 payments
- Shafeeq Ladha Phoenix, AZ Named on 3 payments
- Michael Benatar Miami, FL Named on 2 payments
- Gary Pattee Lincoln, NE Named on 2 payments
- Nicholas Maragakis Baltimore, MD Named on 2 payments
- John Katz San Francisco, CA Named on 2 payments
- Jeremy Shefner Syracuse, NY Named on 2 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.